DK0778025T3 - Anvendelse af 8,9-dehydroestron til fremstilling af et lægemiddel til behandling af sygdomme, der er forårsaget af frie radikaler - Google Patents
Anvendelse af 8,9-dehydroestron til fremstilling af et lægemiddel til behandling af sygdomme, der er forårsaget af frie radikalerInfo
- Publication number
- DK0778025T3 DK0778025T3 DK96308632T DK96308632T DK0778025T3 DK 0778025 T3 DK0778025 T3 DK 0778025T3 DK 96308632 T DK96308632 T DK 96308632T DK 96308632 T DK96308632 T DK 96308632T DK 0778025 T3 DK0778025 T3 DK 0778025T3
- Authority
- DK
- Denmark
- Prior art keywords
- dehydroestrone
- drug
- manufacture
- treatment
- free radicals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US793195P | 1995-12-04 | 1995-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0778025T3 true DK0778025T3 (da) | 2004-06-07 |
Family
ID=21728885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96308632T DK0778025T3 (da) | 1995-12-04 | 1996-11-28 | Anvendelse af 8,9-dehydroestron til fremstilling af et lægemiddel til behandling af sygdomme, der er forårsaget af frie radikaler |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0778025B1 (ko) |
| JP (1) | JPH09169650A (ko) |
| KR (1) | KR100444002B1 (ko) |
| CN (1) | CN1104900C (ko) |
| AR (2) | AR005866A1 (ko) |
| AT (1) | ATE263565T1 (ko) |
| AU (1) | AU703814B2 (ko) |
| BR (1) | BR9605777A (ko) |
| CA (1) | CA2191835A1 (ko) |
| CZ (1) | CZ289780B6 (ko) |
| DE (1) | DE69632117T2 (ko) |
| DK (1) | DK0778025T3 (ko) |
| ES (1) | ES2215187T3 (ko) |
| HK (1) | HK1010095A1 (ko) |
| HU (1) | HUP9603329A3 (ko) |
| IL (1) | IL119744A (ko) |
| MX (1) | MX9606009A (ko) |
| NO (1) | NO312654B1 (ko) |
| NZ (1) | NZ299858A (ko) |
| PT (1) | PT778025E (ko) |
| SI (1) | SI0778025T1 (ko) |
| SK (1) | SK154296A3 (ko) |
| ZA (1) | ZA969923B (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19723794A1 (de) * | 1997-06-06 | 1998-12-10 | Jenapharm Gmbh | Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität |
| US9557325B2 (en) | 2003-06-09 | 2017-01-31 | Redox-Reactive Reagents Llc | Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| US7892751B2 (en) | 2003-06-09 | 2011-02-22 | Redox-Reactive Reagents Llc | Method of detecting or diagnosing of a neurodegenerative disease or condition |
| CN1832756A (zh) * | 2003-06-09 | 2006-09-13 | 约翰·A·麦金太尔 | 通过氧化还原反应改变血浆蛋白质结合专一性的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210081A (en) * | 1992-02-26 | 1993-05-11 | American Home Products Corporation | Alkali metal 8,9-dehydroestrone sulfate esters |
| DE4334823C2 (de) * | 1993-10-09 | 1998-09-17 | Schering Ag | Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen |
| US5395831A (en) * | 1994-04-08 | 1995-03-07 | American Home Products Corporation | Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone |
| DE19509729A1 (de) * | 1995-03-13 | 1996-09-19 | Schering Ag | 17-Difluormethylen-Estratriene |
-
1996
- 1996-11-25 AU AU71944/96A patent/AU703814B2/en not_active Ceased
- 1996-11-26 ZA ZA9609923A patent/ZA969923B/xx unknown
- 1996-11-27 AR ARP960105366A patent/AR005866A1/es not_active Application Discontinuation
- 1996-11-28 DK DK96308632T patent/DK0778025T3/da active
- 1996-11-28 EP EP96308632A patent/EP0778025B1/en not_active Expired - Lifetime
- 1996-11-28 AT AT96308632T patent/ATE263565T1/de not_active IP Right Cessation
- 1996-11-28 SI SI9630674T patent/SI0778025T1/xx unknown
- 1996-11-28 PT PT96308632T patent/PT778025E/pt unknown
- 1996-11-28 DE DE69632117T patent/DE69632117T2/de not_active Expired - Fee Related
- 1996-11-28 ES ES96308632T patent/ES2215187T3/es not_active Expired - Lifetime
- 1996-12-02 MX MX9606009A patent/MX9606009A/es not_active IP Right Cessation
- 1996-12-02 CA CA002191835A patent/CA2191835A1/en not_active Abandoned
- 1996-12-02 BR BR9605777A patent/BR9605777A/pt not_active Application Discontinuation
- 1996-12-02 SK SK1542-96A patent/SK154296A3/sk unknown
- 1996-12-02 NZ NZ299858A patent/NZ299858A/en unknown
- 1996-12-03 CZ CZ19963532A patent/CZ289780B6/cs not_active IP Right Cessation
- 1996-12-03 NO NO19965165A patent/NO312654B1/no unknown
- 1996-12-03 HU HU9603329A patent/HUP9603329A3/hu unknown
- 1996-12-03 KR KR1019960061345A patent/KR100444002B1/ko not_active IP Right Cessation
- 1996-12-03 CN CN96123342A patent/CN1104900C/zh not_active Expired - Fee Related
- 1996-12-03 IL IL11974496A patent/IL119744A/xx not_active IP Right Cessation
- 1996-12-03 JP JP8322539A patent/JPH09169650A/ja not_active Ceased
-
1998
- 1998-09-24 HK HK98110925A patent/HK1010095A1/xx not_active IP Right Cessation
-
2007
- 2007-03-19 AR ARP070101105A patent/AR059965A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO965165D0 (no) | 1996-12-03 |
| IL119744A0 (en) | 1997-03-18 |
| BR9605777A (pt) | 1998-08-25 |
| KR100444002B1 (ko) | 2004-11-03 |
| NZ299858A (en) | 2001-03-30 |
| NO965165L (no) | 1997-06-05 |
| ATE263565T1 (de) | 2004-04-15 |
| HK1010095A1 (en) | 1999-06-11 |
| CN1158725A (zh) | 1997-09-10 |
| ZA969923B (en) | 1998-05-26 |
| SI0778025T1 (en) | 2004-08-31 |
| AR005866A1 (es) | 1999-07-21 |
| ES2215187T3 (es) | 2004-10-01 |
| AU703814B2 (en) | 1999-04-01 |
| CZ353296A3 (en) | 1997-08-13 |
| PT778025E (pt) | 2004-08-31 |
| CN1104900C (zh) | 2003-04-09 |
| AU7194496A (en) | 1997-06-12 |
| EP0778025B1 (en) | 2004-04-07 |
| DE69632117D1 (de) | 2004-05-13 |
| HUP9603329A2 (en) | 1997-08-28 |
| CZ289780B6 (cs) | 2002-04-17 |
| AR059965A2 (es) | 2008-05-14 |
| SK154296A3 (en) | 1997-08-06 |
| HUP9603329A3 (en) | 1998-01-28 |
| MX9606009A (es) | 1997-08-30 |
| JPH09169650A (ja) | 1997-06-30 |
| NO312654B1 (no) | 2002-06-17 |
| EP0778025A1 (en) | 1997-06-11 |
| DE69632117T2 (de) | 2004-08-26 |
| HU9603329D0 (en) | 1997-01-28 |
| KR970032870A (ko) | 1997-07-22 |
| IL119744A (en) | 2003-01-12 |
| CA2191835A1 (en) | 1997-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20105844A (fi) | Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon | |
| NO307968B1 (no) | Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav | |
| DK1425001T3 (da) | Phenethanolaminderivater til behandling af respiratoriske sygdomme | |
| DK0769947T3 (da) | Indolinonforbindelser til behandling af sygdom | |
| DE69105829D1 (de) | Nasenmaske. | |
| DK1155695T3 (da) | Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse | |
| NO995221D0 (no) | Sulfonamider for behandling av endotelinmedierte sykdommer | |
| EE200300214A (et) | Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks | |
| DK0979079T3 (da) | Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering | |
| DK19893A (da) | Praeparat til nasal behandling | |
| DK0501705T3 (da) | Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje | |
| DK0467564T3 (da) | Behandling af inflammatoriske sygdomme med 15-ketoprostaglandinforbindelser | |
| NO975660D0 (no) | Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi | |
| DK0778025T3 (da) | Anvendelse af 8,9-dehydroestron til fremstilling af et lægemiddel til behandling af sygdomme, der er forårsaget af frie radikaler | |
| DE69618560D1 (de) | Medikament gegen ophthalmische erkrankungen | |
| DK0874843T3 (da) | Substituerede 4-(1H-benzimidazol-2-yl)(1,4)diazepaner, der er nyttige til behandling af allergisygdomme | |
| EE03384B1 (et) | Melatoniini kasutamine ravimi tootmiseks | |
| NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
| EE03437B1 (et) | Benseenamiidid neurodegeneratiivsete haiguste ravimiseks | |
| DK101197A (da) | Medikament til behandling af thrombocytopenia | |
| NO20032006L (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser | |
| DK0866699T3 (da) | Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi | |
| DK0454429T3 (da) | Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme | |
| DK0671910T3 (da) | Anvendelse af adamantanderivater til fremstilling af et lægemiddel til behandling af glaucoma | |
| FI951041A (fi) | (S)-(-)-alfa-etyyli-2-okso-1-pyrrolidiiniasetamidin käyttö valmistettaessa farmaseuttinen valmiste ahdistuksen hoitoon |